Senior Analyst, Drug Development & Clinical Strategy

Flagship Pioneering, Inc.; Cambridge; Sur place; GBP 60 000 - 95 000; Plein temps

Résumé du poste

Quotient Therapeutics seeks a Senior Analyst to support strategic decisions across its drug development pipeline. You will combine analytical rigor with clinical insight to identify high-value opportunities and inform indications, patient segments, and development paths.

The role may be UK or US-based and reports to the Chief Development Officer. You will build market landscapes, forecast opportunities, and partner with drug development, finance, and external experts to validate segments and

Qualifications

• Bachelor's degree in health sciences or a related field.
• 3+ years with pharmaceutical/biotech product planning or commercial strategy.
• Experience in at least one disease segment: CV, renal, metabolic, oncology, autoimmune.
• Familiarity with drug development strategy and regulatory pathways.
• Experience with healthcare or life-sciences databases.

Responsabilités

• Understand addressable markets, industry landscape, and needs across sectors.
• Carry out market sizing and competitive analysis using diverse data sets.
• Validate market segments with clinical and external expert input.
• Develop asset and disease area valuation models (e.g., rNPV) for BD and finance.
• Create data models and analytical frameworks for stakeholder decision-making.
• Develop dashboards, revenue forecasts, and pipeline scenario analyses.
• Prototype AI-enabled tools and analytics to support analyses.
• Provide insights to inform target-setting and development planning.

Connaissances

Analytical thinking

Strategic thinking

Market analysis

Data visualization

Stakeholder communication

Formation

Bachelor's degree in health sciences or related field

MD/PhD or other advanced degree (Desirable)

Outils

SQL

R or Python

Market research tools

Description du poste

Position Summary

Quotient is seeking a highly analytical and scientifically curious Senior Analyst to support strategic decision-making across our growing drug development pipeline. This is an exciting opportunity to work at the intersection of analytics, market intelligence, commercial strategy and early drug development in a genetics-based biotech company. The successful candidate will combine strong analytical skills and familiarity with scientific and clinical data with commercial curiosity, to turn networks of complex data into meaningful insights. In doing so, the successful candidate will help us better understand where high-value, tractable drug development opportunities exist across our internal pipeline of drug targets, and more broadly across a range of disease areas. Together with other members of the drug development team, this role will help focus which indications, patient segments, and development paths we should consider, and where data can help inform our investment and planning decisions. This role could be based in our UK or US office and will report to the Chief Development Officer.

Responsibilities

• Across a range of disease/therapeutic areas, build a deep understanding of addressable markets, industry landscape, customer (health care practitioner, payor, and patient) needs, and forecast future states and opportunities for growth in sectors of interest
• Carry out market sizing, competitive analysis using epidemiology, clinical, and commercial data sets, and validate through research with external experts
• Partner with clinical, drug development and external experts/customers to further validate specific market segments and develop target product profiles (TPPs)
• Partner with Finance, Business development, and Drug Development teams to develop asset and disease area valuation models (e.g., rNPV) and support BD and finance discussions with valuation and commercial forecast models as required
• Design and improve data models, analytical frameworks, and output formats, that support assessments, presentation to stakeholders and internal decision-making
• Develop dashboards, reporting, and analysis tools to communicate outputs and disease area strategy. Develop and maintain revenue forecasts, pipeline models, and scenario analyses.
• Prototype, test, and help deploy AI-enabled tools, agents, and other analytical resources to support all the above analyses; working with end users and internal teams to refine successful solutions
• Provide insights to drug development, project management, and finance teams to support target-setting and internal development planning.

Qualifications

Essential

• Bachelor's degree in health sciences discipline or a related field
• 3+ years of experience working in or with pharmaceutical or biotech companies (including via consulting firms) in product planning or commercial strategy teams
• Experience in at least one of these disease segments: Cardiovascular, renal, metabolic, oncology, autoimmune diseases
• Familiarity with drug development strategy and regulatory pathways
• Experience with a range of healthcare or life-sciences databases and market research tools
• Exposure to valuation, business development, licensing, or investment analysis
• Strong analytical and research skills
• Familiarity with and ability to synthesize scientific, medical, and economic data
• Strong business acumen and problem-solving capabilities
• Strong written and verbal communication skills
• Ability to work independently yet collaboratively, manage multiple projects, and meet deadlines

Desirable

• MD, PhD, or other advanced degree
• 4-6+ years of industry experience
• Knowledge of genomic-based approaches to drug target discovery

Values and Behaviors

• Encourage respectful disagreement and cultivate open-minded, ego-free interactions to continuously push each other towards excellence
• Seek out diverse perspectives; practice active listening and genuine curiosity to ensure all contributions are valued, regardless of source
• Recognize the impact of your behavior, language and attitudes, and strive for balanced, meaningful exchanges that enhance mutual growth and understanding in all interactions
• Use a company-first mindset to guide decision-making; prioritize team over individual success
• Take calculated risks and challenge convention in the quest for exceptional outcomes

About Quotient

Quotient Therapeutics is a privately-held, early stage company developing breakthrough medicines informed by natural somatic genetic diversity present in patients. Through our work in somatic genomics, we are forging a new status quo for biopharma research and development across a broad pipeline of internal and partnered programs.

The company was founded by Flagship Pioneering, an innovative enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Generate Biomedicines, Sana Biotechnology (SANA), Tessera Therapeutics, Evelo Biosciences (EVLO), Indigo Agriculture, Seres Therapeutics (MCRB), and Syros Pharmaceuticals (SYRS).

Quotient Therapeutics and Flagship Pioneering are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.